EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Association of Gut Microbiome Dynamics With Systemic Inflammation and Disease‐Free Survival in Osteosarcoma Patients

Sofia Avnet iD, Federica D'Amico, Luigi Falzetti iD, Gemma Di Pompo, Alessandro Pasquarelli, Alessandra Longhi iD, Costantino Errani iD, Patrizia Brigidi, Silvia Turroni iD, Nicola Baldini

Cancer Medicine · 2026-11 · 15 (11)

DOI: 10.1002/cam4.72399 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 11.11.2026. Verfasst von Sofia Avnet und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Osteosarcoma, Gastrointestinal Microbiome, Inflammation, Bone Neoplasms. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gut microbiota (GM) is increasingly recognised as a key modulator of cancer development, progression, and treatment response. However, clinical studies remain limited, especially in osteosarcoma (OS), the most common bone cancer in children and adolescents. In this study, we analysed GM diversity, composition, and predicted function in a small OS cohort ( n = 18) using 16S rRNA gene sequencing of stool samples collected at diagnosis, during chemotherapy, and post‐treatment. Microbial profiles were compared to healthy controls. Alpha diversity was assessed via ASVs, Shannon, inverse Simpson, and Faith's index; beta diversity via Bray‐Curtis and UniFrac distances. We examined associations between GM profiles and clinical variables (age, gender, BMI, tumour volume, outcome) and systemic inflammation (e.g., C‐reactive protein, CRP) using PERMANOVA, LEfSe, and Kaplan–Meier analysis. At diagnosis, OS patients showed reduced diversity and a distinct GM signature—depletion of anti‐inflammatory genera ( Blautia, Faecalibacterium, Roseburia ) and enrichment of potentially pro‐tumorigenic taxa ( Collinsella, Streptococcus ), which correlated with elevated CRP. Baseline GM composition stratified patients by long‐term outcome, with specific taxa and predicted pathways linked to event‐free survival. Chemotherapy induced transient dysbiosis, notably affecting Lactobacillus and Enterococcus , with partial recovery post‐treatment. This is the first study to track GM alterations in OS patients across the disease course, extending current knowledge beyond preclinical models. As one of the few longitudinal microbiota studies in oncology, it highlights GM's potential as a biomarker, shedding light on the mechanisms underlying OS pathogenesis, though findings require validation in larger cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaGastrointestinal MicrobiomeInflammationBone NeoplasmsHumansFemaleMaleAdolescentChildDisease-Free SurvivalRNA, Ribosomal, 16SFeces

Stichwörter der Autor:innen

chemotherapygut microbiotamonocentricobservational clinical studyosteosarcoma

Substanzen

RNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
  • Unit of Microbiome Science and Biotechnology, Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
  • Biomedical Science and Technologies and Nanotechnology Lab, IRCSS Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Osteoncologia, Sarcomi Ossei e Dei Tessuti Molli e Terapie Innovative, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Department of Orthopaedic Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Human Microbiomics Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

ORCID-Profile: Sofia Avnet, Luigi Falzetti, Alessandra Longhi, Costantino Errani, Silvia Turroni

Förderung

  • Ministero della Salute

Zitieren

APA

Avnet, S., D'Amico, F., Falzetti, L., Di Pompo, G., Pasquarelli, A., Longhi, A., Errani, C., Brigidi, P., Turroni, S., & Baldini, N. (2026). Association of Gut Microbiome Dynamics With Systemic Inflammation and Disease‐Free Survival in Osteosarcoma Patients. Cancer Medicine, 15(11). https://doi.org/10.1002/cam4.72399

Vancouver

Avnet S, D'Amico F, Falzetti L, Di Pompo G, Pasquarelli A, Longhi A, et al. Association of Gut Microbiome Dynamics With Systemic Inflammation and Disease‐Free Survival in Osteosarcoma Patients. Cancer Medicine. 2026;15(11). doi:10.1002/cam4.72399

BibTeX
@article{Avnet2026,
  author = {Avnet, Sofia and D'Amico, Federica and Falzetti, Luigi and Di Pompo, Gemma and Pasquarelli, Alessandro and Longhi, Alessandra and Errani, Costantino and Brigidi, Patrizia and Turroni, Silvia and Baldini, Nicola},
  title = {Association of Gut Microbiome Dynamics With Systemic Inflammation and Disease‐Free Survival in Osteosarcoma Patients},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {11},
  doi = {10.1002/cam4.72399}
}
Kostenlos starten →